Lesofavumab Biosimilar - Research Grade

Human

influenza B virus hemagglutinin [Influenza B virus]

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Blue ice

Antibodies that bind influenza B virus hemagglutinin are valuable tools for studying viral entry, antigenic variation, and neutralization. This human IgG1, kappa reagent is an unconjugated, non-therapeutic analog of lesofavumab that recognizes influenza B virus hemagglutinin for functional and infectious-disease research. It is purified to a low-endotoxin grade appropriate for in vivo experiments and manufactured at scalable milligram-to-gram volumes to support bulk and high-throughput workflows. Offered for research use only (RUO), it works as a positive binding control and active reagent in hemagglutination-inhibition and neutralization assays, antigen-detection panels, and preclinical influenza infection models.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks